Search Results 6091-6100 of 34525 for oral

  1. Gadodiamide (intravenous route) - Side effects & uses - Mayo Clinic

    Gadodiamide injection is a magnetic resonance imaging (MRI) contrast agent used to help create a clear picture of the body during an MRI scan. MRI scans use ...

  2. Dental implant surgery - Doctors & Departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Journal of Oral and Maxillofacial Surgery. 2023; https://www.clinicalkey ...

  3. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...

  4. Atenolol for the Prevention of Osteoporosis (APO) - Mayo Clinic

    - adrenocorticosteroids (oral for > 3 months within the past year or sustained inhaled corticosteroid use) - anticonvulsant therapy for seizures ...

  5. A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) - Mayo Clinic

    Participant is taking an oral mTOR inhibitor. Participant has any known or suspected hypersensitivity to cannabinoids or any of the excipients of the ...

  6. Tools To Detect The Effect Of Hypomethylating Agents And Examination Of Protein Interactions Predicting Response To Therapy In Acute Myeloid Leukemia - Mayo Clinic

    Patients with gastrointestinal tract disease causing the inability to take oral medication, malabsorption syndrome, requirement for intravenous alimentation ...

  7. A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway - Mayo Clinic

    swallow oral medications. Note: Other protocol defined Inclusion/Exclusion criteria may apply. Eligibility last updated 1/27/23. Questions regarding updates ...

  8. A Study to Evaluate Pomalidomide to Treat Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    A total of 159 patients will be randomized 2:1 to treatment with oral pomalidomide or matching placebo for 24 weeks. Mean change from baseline to 24 weeks ...

  9. A Study of the Effect of Colesevelam on Glucose Metabolism in Patients with Type 2 Diabetes - Mayo Clinic

    ... oral hypoglycemics), Byetta or a sulfonylurea agent in the past three months; HbA1c greater than 9.0%; Have not been stable on all medications for a period ...

  10. Detection of Esophageal Cancer by Assay of Novel Methylated DNA Markers in Plasma - Mayo Clinic

    Oral contrast given within 7 days of stool collection; Removal of more than 50% of colon or presence of ileostomy; Enteral feeds or TPN; Diagnosis of ...